P

Inventor

ZHOU HEYUE

US58 patents
⚠️ This page may combine multiple inventors who share the name “ZHOU HEYUE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SORRENTO THERAPEUTICS INC

44 patents
US10058609B2Aug 28, 2018

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC17 citations93
US9676853B2Jun 13, 2017

Antigen binding proteins that bind PD-1

SORRENTO THERAPEUTICS INC15 citations92
US10233251B2Mar 19, 2019

Antibody therapeutics that bind CD137

SORRENTO THERAPEUTICS INC7 citations84
US10118963B2Nov 6, 2018

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC12 citations84
US10100118B2Oct 16, 2018

Antibody therapeutics that bind CD123

SORRENTO THERAPEUTICS INC6 citations84
US10059774B2Aug 28, 2018

Antibody therapeutics that bind CD38

SORRENTO THERAPEUTICS INC6 citations84
US10035855B2Jul 31, 2018

Antibody therapeutics that bind CD47

SORRENTO THERAPEUTICS INC8 citations84
US10519245B2Dec 31, 2019

Antibodies which bind insulin-like growth factor receptor-1 (IGF1R) and methods of use thereof to treat cancer

SORRENTO THERAPEUTICS INC6 citations83
US10377827B2Aug 13, 2019

Antigen binding proteins that bind c-met

SORRENTO THERAPEUTICS INC14 citations83
US11180568B2Nov 23, 2021

Antibody therapeutics that bind CD137

SORRENTO THERAPEUTICS INC3 citations73
US11174314B2Nov 16, 2021

Anti-KRAS binding proteins

SORRENTO THERAPEUTICS INC2 citations73
US10934361B2Mar 2, 2021

Antibody therapeutics that bind CD123

SORRENTO THERAPEUTICS INC2 citations73
US10919964B2Feb 16, 2021

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC2 citations73
US10800852B2Oct 13, 2020

Antibody therapeutics that bind CD38

SORRENTO THERAPEUTICS INC3 citations73
US9951144B2Apr 24, 2018

Antibody therapeutics that bind CD38

SORRENTO THERAPEUTICS INC2 citations73
US9902772B2Feb 27, 2018

Antibody therapeutics that bind LAG3

SORRENTO THERAPEUTICS INC5 citations73
US12084503B2Sep 10, 2024

Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment

SORRENTO THERAPEUTICS INC2 citations72
US10584168B2Mar 10, 2020

Antigen binding proteins that bind PD-1

SORRENTO THERAPEUTICS INC1 citations72
US10472413B2Nov 12, 2019

Anti-infective binding proteins that bind AIP2

SORRENTO THERAPEUTICS INC1 citations72
US9315579B2Apr 19, 2016

Antigen binding proteins that bind CCR2

SORRENTO THERAPEUTICS INC3 citations71
US10435476B2Oct 8, 2019

Antibody therapeutics that bind JAG1

SORRENTO THERAPEUTICS INC4 citations68
US9873741B2Jan 23, 2018

Antibody therapeutics that bind TIM3

SORRENTO THERAPEUTICS INC2 citations68
US11760806B2Sep 19, 2023

CD-38 directed chimeric antigen receptor constructs

SORRENTO THERAPEUTICS INC2 citations65
US11999792B2Jun 4, 2024

Antibody therapeutics that bind CD38

SORRENTO THERAPEUTICS INC0 citations62
US11878058B2Jan 23, 2024

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC0 citations62
US11746156B2Sep 5, 2023

Antibody therapeutics that bind CD123

SORRENTO THERAPEUTICS INC0 citations62
US11318202B2May 3, 2022

Antigen binding proteins that bind WISP1

SORRENTO THERAPEUTICS INC0 citations62
US11242391B2Feb 8, 2022

Antigen binding proteins that bind PD-1

SORRENTO THERAPEUTICS INC0 citations62
US11155623B2Oct 26, 2021

Antibody therapeutics that bind CTLA4

SORRENTO THERAPEUTICS INC1 citations62
US11111304B2Sep 7, 2021

Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2)

SORRENTO THERAPEUTICS INC0 citations62
US11027012B2Jun 8, 2021

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC0 citations62
US10272154B2Apr 30, 2019

Antigen binding proteins that bind WISP1

SORRENTO THERAPEUTICS INC1 citations62
US10202453B2Feb 12, 2019

Antibody therapeutics that bind CTLA4

SORRENTO THERAPEUTICS INC1 citations62
US9631009B2Apr 25, 2017

Anti-infective binding proteins that bind AIP2

SORRENTO THERAPEUTICS INC1 citations61
US11155628B2Oct 26, 2021

Antigen binding proteins that bind c-Met

SORRENTO THERAPEUTICS INC0 citations60
US10174107B2Jan 8, 2019

Antigen binding proteins that bind delta-like 4 (DLL-4)

SORRENTO THERAPEUTICS INC1 citations60
US11191845B2Dec 7, 2021

CD38 antibody drug conjugate

SORRENTO THERAPEUTICS INC0 citations58
US10927171B2Feb 23, 2021

Antibody therapeutics that bind TIM3

SORRENTO THERAPEUTICS INC0 citations58
US9879069B2Jan 30, 2018

Antibody therapeutics that bind OprF

SORRENTO THERAPEUTICS INC0 citations52
US10696746B2Jun 30, 2020

Antigen binding proteins that bind CCR2

SORRENTO THERAPEUTICS INC0 citations51
US10301386B2May 28, 2019

Antibody therapeutics that bind CD147

SORRENTO THERAPEUTICS INC0 citations51
US9951138B2Apr 24, 2018

Antigen binding proteins that bind CCR2

SORRENTO THERAPEUTICS INC0 citations51
US9944707B2Apr 17, 2018

Antibodies that bind epidermal growth factor receptor (EGFR)

SORRENTO THERAPEUTICS INC1 citations51
US10717779B2Jul 21, 2020

Methods for blocking an interaction between notch-1 and delta-like 4 (DLL-4) by administering a DDL-4 antibody

SORRENTO THERAPEUTICS INC0 citations50

GRAY JOHN DIXON

2 patents

ZHOU HEYUE

1 patent

KAUFMANN GUNNAR F

1 patent

YUHAN CORP

1 patent

GASTWIRT RANDY

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.